Skip to main content
Tech.euFundingExplorerBeta

Kintsugi Therapeutics

Kintsugi Therapeutics is a preclinical biopharmaceutical company focused on the development of drugs for the treatment of metabolic and neurodegenerative diseases.

Total raised
€986k
€986,000
Funding rounds
1
Investors
1
distinct backers
Active since
2021-11
latest 2021-11

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood12
base rate 34% for Crowdfunding
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2021-11-11Crowdfunding€986kCapital CellView deal →

Investors

1

Similar companies

same sector or country